Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
August 08, 2024 07:00 ET
|
Eyenovia, Inc.
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today...
BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
August 08, 2024 06:00 ET
|
BioVie, Inc.
SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson’s disease who are naïve to carbidopa/levodopa Company engaged in trial start-up...
Dr. Brian Buinewicz is a Featured Speaker at the 2024 Breast Implant Illness Summit
August 08, 2024 00:42 ET
|
Buinewicz Plastic Surgery
DOYLESTOWN, Pa., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Board-certified plastic surgeon Dr. Brian Buinewicz, known for offering a wide a range of cosmetic and functional procedures at Buinewicz Plastic...
Greg Horn Honored with NBJ Lifetime Achievement Award For Transformative Impact on Health and Wellness
August 07, 2024 16:28 ET
|
Specialty Nutrition Consulting
Nutrition Business Journal honored Greg Horn with the prestigious NBJ Lifetime Achievement Award at the NBJ Summit for his transformative impact on health.
Breakthrough Study Reveals Molecular Subtypes of Down Syndrome, Offering Insights for Personalized Medicine Approaches
August 07, 2024 16:27 ET
|
Global Down Syndrome Foundation
Denver, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Global Down Syndrome Foundation (GLOBAL) is proud to support a new study published in Nature Communications by researchers at its partner and Affiliate,...
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance Ranges
August 07, 2024 16:10 ET
|
RadNet, Inc.
Total Company Revenue increased 13.9% to $459.7 million in the second quarter of 2024 from $403.7 million in the second quarter of 2023; Revenue from the Digital Health reportable segment (inclusive...
EGFR Inhibitors-Induced Skin Disorders Market to Observe Impressive Growth During the Study Period (2020–2034) | DelveInsight
August 07, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- EGFR Inhibitors-Induced Skin Disorders Market to Observe Impressive Growth During the Study Period (2020–2034) | DelveInsight The EGFR...
Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight
August 07, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The growing global prevalence of...
XYMOGEN XPERIENCE Dedicated Exclusively to Elevating Women’s Health
August 07, 2024 10:00 ET
|
XYMOGEN
Nutraceutical company XYMOGEN, features JJ Virgin and an all-female speaker lineup for its Fall 2024 XYMOGEN XPERIENCE focused on women's health topics.
Dental Loupe Market to Reach $619.2 Million, Globally, by 2033 at 7.9% CAGR: Allied Market Research
August 07, 2024 09:48 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Dental Loupe Market by Product Type (Clip-On Loupe, and Headband Mounted Loupe), and End...